Making Health Care Work

LOWERING HEALTH CARE COSTS—We’re working to cut costs by cutting waste and focusing on prevention and care that get results.

LOWER COSTS, BETTER CARE

It’s a big year for health care. Many people have new options for coverage. And new protections are making existing health insurance work better. Take a look at our latest resources to help you make the most of the changes:

Health Insurance Tips - Top tips on getting the best deal on health insurance, and information about new consumer protections

So You Need Health Insurance, Now What? - The new young person's guide to health insurance

We’re excited to get the word out about these new options and consumer protections. But we also know there’s more to do to really make health care work across America. That’s why we’re advancing new initiatives to cut waste, improve care, and give consumers more control over their health.

The Health Insurance Marketplace

The state and federal health insurance marketplaces can help consumers and small businesses find a better deal on health coverage, with tools to compare plans, and information about new financial help. We’re working to make sure these marketplaces meet their potential to boost competition, reduce costs and improve quality.

Health Insurance Rate Watch

It’s time for health insurance companies to get serious about lowering the cost of care by cutting waste and focusing on preventive care that gets results – instead of raising deductibles and hiking premiums. We’re tracking insurers’ health insurance rate increase proposals, and working to strengthen protections for consumers and small businesses against excessive rates.

Fighting the High Cost of Rx Drugs

According to the Federal Trade Commission, Americans spend at least $3.5 billion more than they should have to on prescription drugs every year. That’s because drug companies use a practice called “pay for delay” to pay off their competitors to delay availability of the lower priced generic version of the drug. We’re working to put a stop to this practice.


Learn more about our priority campaign to end the pharmaceutical industry's scheme to delay cheaper drugs from entering the market:

Issue updates

Report | U.S. PIRG Education Fund | Health Care

Paying the Price 2006

During the spring of 2006, researchers from the state Public Interest Research Groups (PIRGs) posed as uninsured customers and surveyed by phone hundreds of pharmacies in 35 cities across the country to determine how much uninsured consumers are paying for 10 prescription drugs commonly used by adults under age 65. We then compared these prices with the prices the pharmaceutical companies charge the federal government; with prices at a Canadian pharmacy; and with the results of a similar survey we completed in 2004.

> Keep Reading
Report | U.S. PIRG | Health Care

Turning Medicine Into Snake Oil

Prescription drug marketers are inundating doctors, and to a lesser extent, the public, with marketing that misrepresents risks, promotes unproven uses, and makes unsubstantiated claims. The false and misleading messages are communicated through conventional advertising, sales representatives, doctors speaking on behalf of drug marketers, and through clinical trial suppression, manipulation and misrepresentation. Sadly, the Food and Drug Administration (FDA) is ineffective at addressing the problems.

> Keep Reading
Report | U.S. PIRG | Health Care

Paying the Price 2004

In late summer of 2004, the PIRGs conducted a survey of more than 400 pharmacies in 19 states across the country and Washington, DC to determine how much uninsured consumers are paying for 12 prescription drugs commonly used by adults under age 65. We then compared these prices with the prices the pharmaceutical companies charge one of their “most favored” customers, the federal government, and also with the prices paid by consumers in Canada.

> Keep Reading
Report | U.S. PIRG Education Fund | Health Care

Paying the Price 2003

In the spring of 2003, the National Association of State Public Interest Research Groups (PIRGs) conducted a survey of more than 500 pharmacies in 18 states across the country and Washington, D.C. to determine how much uninsured consumers are paying for 10 common prescription drugs. We then compared these prices with the prices the pharmaceutical companies charge one of their “most favored” customers, the federal government.

> Keep Reading
Report | U.S. PIRG | Health Care

D.C. Area Consumers Pay More for Prescription Drugs While Pharmaceutical Profits Soar

A price survey of 33 pharmacies in the D.C. Area, conducted by the national consumer groups Public Citizen, U.S. PIRG and the D.C. chapter of the Gray Panthers shows that consumers who lack prescription drug coverage are being charged retail prices that are nearly double the prices prescription drug makers charge their most favored customers.

> Keep Reading

Pages

View AllRSS Feed

Support us

We’ve got a chance to clean up the health care industry, but with lobbyists lining the halls of state capitols across the country, we need your support.

PRIORITY ACTION

Tell your senator that patients can't afford to wait another day. We need to end "Pay for Delay" right now.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.